1. Home
  2. LSTA vs FRSX Comparison

LSTA vs FRSX Comparison

Compare LSTA & FRSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.02

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Logo Foresight Autonomous Holdings Ltd.

FRSX

Foresight Autonomous Holdings Ltd.

HOLD

Current Price

$1.50

Market Cap

6.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSTA
FRSX
Founded
1980
N/A
Country
United States
Israel
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
6.3M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
LSTA
FRSX
Price
$2.02
$1.50
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$23.50
N/A
AVG Volume (30 Days)
23.6K
583.7K
Earning Date
11-06-2025
03-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,070,000.00
$452,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.81
$1.52
52 Week High
$4.20
$18.41

Technical Indicators

Market Signals
Indicator
LSTA
FRSX
Relative Strength Index (RSI) 47.86 29.61
Support Level $2.00 $1.52
Resistance Level $2.17 $1.74
Average True Range (ATR) 0.10 0.10
MACD 0.02 -0.02
Stochastic Oscillator 52.00 11.90

Price Performance

Historical Comparison
LSTA
FRSX

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

About FRSX Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings Ltd is a technology company engaged in the design, development and commercialization of vision systems for the automotive industry. The company develops both in-line-of-sight vision systems and beyond-line-of-sight cellular-based applications through its wholly-owned subsidiaries. Its systems are designed to improve driving safety by enabling accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is pursuing several markets and believes its modern systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform.

Share on Social Networks: